Built vs. Bought for Enterprise AI 2025: A U.S. Market Framework Decision Framework for AI Product VPs

Enterprise AI in America has passed the testing phase. CFOs expect Clear ROI, boards expect Evidence of Risk OversightExpectations of regulators and. Existing risk management obligations are compatible with controls. Every VP for AI must face the following question. Do we need to build the capability ourselves, purchase it from an outside vendor or combine both?

Truth is, there is nothing else. no universal winner. What is the right answer? Portfolio-specific context specific. This isn’t about “in-house vs outsourced” Abstract, but not about Map each use case according to its strategic differentiation, regulatory scrutiny and execution maturity.

U.S. The U.S.

The AI Act is the EU’s prescriptive rule-making instrument. However, the U.S. has not adopted it. Sector-driven and enforcement led. The real reference for U.S. companies is:

• NIST AI Risk Management Framework (RMF): De facto federal guidelines are shaping the procurement and vendor-assurance programs in agencies, and they have now been reflected by enterprise practices.
• NIST AI600-1 (Generative AI Profil) Clarify evaluation expectations regarding hallucination tests, monitoring and evidence.
• Banking/finance: FDIC/FFIEC Guidance, OCC continues to scrutinize models embedded in underwriting/risk.
• Healthcare: HIPAA + FDA Regulatory Oversight of Algorithms in Clinical Context
• FTC enforcement authority: Take a risk “deceptive practices” citations around transparency/disclosure.
• SEC disclosure expectations: We must start disclosing information about public companies “material AI-related risks”Data use, bias and cybersecurity are of particular concern.

The bottom line for U.S. Leaders: There is currently no AI Act that has been enacted in its entirety. Boards and regulators are testing your governance frameworks, vendor risk management, and model governance.. The pressure is on. Building vs Buying – A Decision To be based on evidence and to be defensible.

Building, Buying, and Blending: the Executive portfolio view

On a strategic basis, you should:

• Build When a particular capability is critical to achieving a competitive edge, if it involves highly sensitive U.S. data regulations (PHIs, PIIs, or financial information), and if the system requires integrating deeply into proprietary systems.
• Buy Vendors can bring you the compliance coverage which is missing in your organization.
• Blend For the vast majority of enterprise U.S. use cases, pair proven vendor platforms with custom solutions (multi-modeling, safety layers and compliance artifacts). “last mile” Working on retrieval, domain evalus and prompts.

Building vs Buying: A 10 Dimensional Framework

Structured debates can help you move past opinionated discussions. Score model. Each dimension is scored 1–5, weighted by strategic priorities.

Decision rules:

• Build if Build score exceeds Buy score by ≥20%.
• Buy if Buy exceeds Build by ≥20%.
• Blend if results are within the ±20% band.

For executives, this turns debates into numbers—and sets the stage for transparent board reporting.

Modelling TCO over a Three-Year Horizon

Compare and contrast is the common method of failure in U.S. companies Costs of a 1-year membership You can also check out our other articles. Costs of 3-year building. Correct decision-making requires like-for-like.

Building TCO (36 Months)

• Internal engineering (AI platform engineering, ML engineering, SRE, Security)
• Cloud Computing (training + inference on GPUs/CPUs). caching layers, autoscaling)
• Data pipelines (ETL, labeling, continuous eval, red-teaming)
• The ability to observe (vector storage, eval data, monitoring pipelines).
• Compliance (SOC 2, HIPAA, HISTA, HRF, NIST RMF, and penetration testing).
• Costs of replication and Egress fees across regions

Purchase TCO for 36 months:

• Seats + subscription/license base
• Charges for usage (tokens or calls?
• Integration/change management uplift
• Add-ons: proprietary RAG, eval and safety layers
• Vendor compliance uplift (SOC 2, HIPAA BAAs, NIST mapping deliverables)
• Migration costs at exit—especially Egress chargesCloud Economics in U.S.

Context): When should you build (U.S. Context)

Best-fit scenarios for Build:

• Strategic IP Underwriting logic, risk scoring, financial anomaly detection—the AI model is central to revenue.
• Data control: PHI or trade secrets cannot be allowed to enter opaque vendor pipelines. HIPAA BAAs often fail to cover all exposures.
• Custom integration The AI system must be integrated into the claims systems, trading platforms or ERP workflows so that they are not easily navigable by outsiders.

Risks:

• Auditors will insist on continuous compliance Evidence artifactsNot policies.
• The U.S. is still a highly competitive market for hiring senior LLMOps Engineers.
• Overspending is predictable: hidden costs such as red teams, evaluation pipelines, and observability are not captured fully in the initial budgets.

What to buy? Context)

Best-fit scenarios for Buy:

• Commodity Tasks Note-taking, Q&A, ticket deflection, baseline code copilots.
• Speed: Senior leadership demands deployment inside a fiscal quarter.
• Vendor-provided compliance: Some vendors are achieving ISO/IEC 42001 Certification.

Risks:

• Vendor lock-in: Some providers offer embeddings and retrieval through APIs that are proprietary.
• Usage volatility: Budgets are unpredictable when token metering is used. The rate limit is governed.
• Exit Costs: The cloud pricing model and the replatforming of platforms can affect ROI. Always demand Exit clauses Data portability is a way to move data.

Blended operating model (default for U.S. enterprises in 2025).

The pragmatic equilibrium can be found in all Fortune 500 companies across the United States. Blend:

• Buy Platform features (Governance, Audit Trails, Multi-Model Routing, RBAC DLP Compliance Attestations),
• Build The last mile: tool adapters for retrieval and evaluation, hallucination test, sector-specific guardrails.

It allows for scale, without compromising on the protection of IP.

Checklist to Conduct Due Diligence on the Vice President of AI

When Buying from Vendors

• Assurance: ISO/IEC 42001+SOC2 + mapping to NISTRMF
• Data Management HIPAA BAA: Retention and minimization, redactions, segregation by region.
• Exit: Negotiated egress fees relief; explicit portability clauses in contract.
• SLAs: Deliverables for bias evaluation, U.S. Data residency, and latency/throughput target.

When Building in-House

• Governance: Operate under NIST AI RMF categories—Measure, govern, and map.
• Architecture: Solid observability pipelines: traces, cost meters, and hallucination metrics.
• People: Dedicated LLMOps teams; embedded evaluation, security experts.
• Cost control: This includes batching requests, optimizing retrieval, and minimizing explicit egress.

The Decision Tree for Senior Executives

1. Does the capability drive a competitive advantage within 12–24 months?
   • Yes → Probable Build.
   • No → Consider Buy.
2. Are you able to demonstrate governance maturity in your organization (aligned with NIST AI RMF?
   • Yes → Lean Build.
   • No → Blend: Buy vendor guardrails, build last-mile.
3. Are the compliance documents of a vendor more likely to satisfy regulators?
   • Yes → Lean Buy/Blend.
   • No → Build to meet obligations.
4. Do internal amortization costs or subscriptions cost have a greater impact on 3-year TCO?
   • Internal lower → Build.
   • Vendor lower → Buy.

Example: U.S. Healthcare Insurer

Consider the following: Automatic claim review and benefit explanation.

• Strategic differentiation: Moderate—efficiency vs competitor baseline.
• HIPAA is concerned with the sensitivity of PHI.
• Clinical decision support is subject to HHS and FDA regulation.
• Integrate with existing claim systems.
• Time-to-value: 6-month tolerance.
• Team maturity: ML However, LLMOps has limited experience.

Outcome:

• Blend. For base LLM+ governance, use a U.S.-based vendor platform that has HIPAA BAA certification and SOC II Type II assurance.
• Create custom retrieval layers and evaluate datasets.
• Maps are not a good idea. NIST AI RMF Evidence for audit committees and board members.

AI VPs: Takeaways

• You can use a Score, Weighted Framework to evaluate each AI use case—this creates audit-ready evidence for boards and regulators.
• Expectations Blended estates to dominate. Retain last-mile control (retrieval, prompts, evaluators) as enterprise IP.
• Align Builds and Buys NIST AI RMFSOC 2, ISO/IEC 42001, as well as sectoral laws in the United States (HIPAA SR11-7).
• Models are always available 3-year TCO including cloud egress.
• Add Exit/portability Clauses Contracts should be signed up-front.

In 2025 the Build or Buy debate will not be about ideologies for U.S. businesses. This is not about ideology. Strategic allocation, governance evidence and execution discipline. VPs of AI who operationalize this decision-making framework will not just accelerate deployment—they will also build resilience against regulatory scrutiny and board risk oversight.

Please feel free to browse our GitHub Page for Tutorials, Codes and Notebooks. Also, feel free to follow us on Twitter Don’t forget about our 100k+ ML SubReddit Subscribe now our Newsletter.